Mitochondrial DNA mutations accumulated in HIV-1-infected children who have an excellent virological response when exposed to long-term antiretroviral therapy
Authors:
- 25 July 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 73 (11) , 3114-3121
Abstract
Objectives: There is growing concern about mitochondrial DNA (mtDNA) mutations with long-term NRTI exposure in HIV-1 infected children. Methods: Twenty-four HIV-1 infected children who started ART more than 2 years earlier who had an excellent virological response and had not changed their regimen were enrolled retrospectively. Their corresponding PBMCs in 2009 (T1), 2010 (T2) and 2013 (T3) were included. Sequencing of the entire mtDNA using next-generation sequencing revealed the spectrum of mtDNA variants. Results: The trend showed that the number of mtDNA mutations during ART occurred as T1 < T2 < T3 (P=0.086). Interestingly, the numbers of whole mtDNA mutations at T3 (median 41, range 24-62) were significantly greater than at T1 (34, 25-46, P=0.029). A positive correlation was found between total mtDNA mutations and treatment time (r=0.352, P=0.002). During the observation period, mtDNA mutations more frequently occurred in the D-loop, cytochrome b (CYTB) and 12S rRNA regions. The heteroplasmic ratio of T3 was higher than that of T1 in CYTB and 12S rRNA (P=0.034 and P=0.042, respectively). High heteroplasmic population levels were found at nt 263 (A263G, D-loop) and nt 8860 (A8860G, ATPase6). A significant difference in heteroplasmy between T1, T2 and T3 occurred at nt 14783 (T14783C, CYTB, P=0.048, T3 > T2 > T1). Conclusions: Our findings reveal the spectrum of mtDNA variants in HIV-1-infected children who had an excellent virological response. mtDNA mutations accumulated during ART may play an important role in facilitating the occurrence of mitochondrial dysfunction.Keywords
Funding Information
- National Natural Science Foundation of China (81601796, 81672026)
- Beijing Natural Science Foundation (7174313)
- Twelfth Key Science and Technology 5-Year Plan of China (2012ZX10001004)
- Beijing Talents Fund Supported Young Backbone project (2015000021469G183)
- Beijing Municipal Institute of Public Medical Research Development (JING YI YAN 2016–2)
- Capital Health Research and Development (2018–1-1151)
- Beijing Municipal Commission of Health and Family (PXM2018_026239_000007)
This publication has 28 references indexed in Scilit:
- Mortality and Treatment Outcomes of China's National Pediatric Antiretroviral Therapy ProgramClinical Infectious Diseases, 2012
- Mitochondrial DNA mutations in disease and agingJournal of Cell Biology, 2011
- Progress of the National Pediatric Free Antiretroviral Therapy program in ChinaAIDS Care, 2010
- Cohort Profile: The Chinese national free antiretroviral treatment cohortInternational Journal of Epidemiology, 2009
- HIV and mitochondrial toxicity in childrenJournal of Antimicrobial Chemotherapy, 2007
- Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspectiveNature Reviews Drug Discovery, 2003
- Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected childrenThe Pediatric Infectious Disease Journal, 2003
- Accumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus–Infected Patients Treated with Nucleoside-Analogue Reverse-Transcriptase InhibitorsThe American Journal of Human Genetics, 2003
- Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected PatientsNew England Journal of Medicine, 2002
- Mitochondrial toxicity of antiviral drugsNature Medicine, 1995